We are live on
!
Find out more
VIA
Virtus Investment Advisers Portfolio holdings
AUM
$363M
1-Year Est. Return
34.89%
This Fund
S&P 500
This Quarter
Est. Return
-1.68%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$368M
AUM Growth
+$240M
(+188%)
Cap. Flow
+$255M
Cap. Flow
% of AUM
69.4%
Top 10 Holdings %
Top 10 Hldgs %
25.49%
Holding
710
New
414
Increased
42
Reduced
13
Closed
237
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Virtus Newfleet ABS/MBS ETF
VABS
|
+$32.2M |
| 2 |
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
|
+$24.8M |
| 3 |
Virtus SEIX Senior Loan ETF
SEIX
|
+$19.2M |
| 4 |
SMC
Summit Midstream
SMC
|
+$4.35M |
| 5 |
OCCI
OFS Credit Co
OCCI
|
+$2.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICICI Bank
IBN
|
+$3.75M |
| 2 |
Virtus Duff & Phelps Clean Energy ETF
VCLN
|
+$2.74M |
| 3 |
Apple
AAPL
|
+$2.06M |
| 4 |
Microsoft
MSFT
|
+$2.02M |
| 5 |
Primoris Services
PRIM
|
+$1.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.48% |
| 2 | Healthcare | 11.95% |
| 3 | Technology | 8.6% |
| 4 | Industrials | 8.02% |
| 5 | Energy | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Edgewise Therapeutics
EWTX
$4.84B
| $128K | 0.03% |
+5,829
| New | +$153K |
|
377
Northern Oil and Gas
NOG
$2.56B
| $127K | 0.03% |
+4,214
| New | +$144K |
|
|
BRY
378
DELISTED
Berry Corp
BRY
| $127K | 0.03% |
39,551
-162,346
| -80% | -$666K |
|
379
Disc Medicine
IRON
$3.01B
| $127K | 0.03% |
+2,556
| New | +$142K |
|
380
Dianthus Therapeutics
DNTH
$6.25B
| $127K | 0.03% |
+6,986
| New | +$154K |
|
381
Scholar Rock
SRRK
$6.32B
| $127K | 0.03% |
+3,939
| New | +$152K |
|
382
SITE Centers
SITC
$158M
| $124K | 0.03% |
+9,696
| New | +$138K |
|
383
Recursion Pharmaceuticals
RXRX
$1.76B
| $124K | 0.03% |
+23,518
| New | +$171K |
|
384
AbCellera Biologics
ABCL
$2.85B
| $124K | 0.03% |
+55,645
| New | +$160K |
|
385
Apple Hospitality REIT
APLE
$3.71B
| $124K | 0.03% |
+9,603
| New | +$140K |
|
|
ITOS
386
DELISTED
iTeos Therapeutics
ITOS
| $123K | 0.03% |
+20,663
| New | +$152K |
|
387
Viridian Therapeutics
VRDN
$2.61B
| $123K | 0.03% |
+9,129
| New | +$155K |
|
|
CIVI
388
DELISTED
Civitas Resources
CIVI
| $122K | 0.03% |
+3,500
| New | +$155K |
|
|
VERV
389
DELISTED
Verve Therapeutics
VERV
| $120K | 0.03% |
+26,348
| New | +$176K |
|
390
MoonLake Immunotherapeutics
MLTX
$1.47B
| $119K | 0.03% |
+3,050
| New | +$131K |
|
391
Allogene Therapeutics
ALLO
$725M
| $119K | 0.03% |
+81,270
| New | +$153K |
|
|
BCAX
392
Bicara Therapeutics
BCAX
$1.82B
| $119K | 0.03% |
+9,097
| New | +$121K |
|
393
Cogent Biosciences
COGT
$7.1B
| $118K | 0.03% |
+19,687
| New | +$154K |
|
394
ArriVent BioPharma
AVBP
$1.44B
| $117K | 0.03% |
+6,348
| New | +$155K |
|
|
AAT
395
American Assets Trust
AAT
$1.38B
| $116K | 0.03% |
+5,765
| New | +$130K |
|
396
uniQure
QURE
$3.2B
| $116K | 0.03% |
+10,906
| New | +$153K |
|
|
SLRN
397
DELISTED
ACELYRIN
SLRN
| $115K | 0.03% |
46,372
+10,672
| +30% | +$25.4K |
|
398
Beam Therapeutics
BEAM
$2.82B
| $114K | 0.03% |
+5,856
| New | +$153K |
|
399
Celldex Therapeutics
CLDX
$3.37B
| $113K | 0.03% |
+6,208
| New | +$139K |
|
400
EyePoint Inc
EYPT
$1.13B
| $112K | 0.03% |
+20,674
| New | +$145K |
|
Similar funds
WI
MS
HS
SIAG
WTFG
A6
ACM
RGC
Virtus Investment Advisers's Q1 2025 Portfolio in Review
As of Q1 2025, Virtus Investment Advisers held 710 positions worth $368M, up 188% from $128M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Virtus Investment Advisers deployed $255M of net new capital in Q1 2025, opening 414 new positions and adding to 42 existing holdings. Its largest new stake was Virtus Newfleet ABS/MBS ETF: 1,321,000 shares worth $32.2M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Berry Corp, an estimated $666K trimmed.
- Virtus Investment Advisers's largest Q1 2025 buy was Virtus Newfleet ABS/MBS ETF: 1,321,000 shares worth $32.2M.
- Virtus Investment Advisers added most to Yum China in Q1 2025, an estimated $1.42M increase.
- Virtus Investment Advisers's biggest Q1 2025 reduction was Berry Corp, cutting an estimated $666K.
- Virtus Investment Advisers fully exited ICICI Bank in Q1 2025, selling an estimated $3.75M.
- Virtus Investment Advisers's ten largest holdings make up 25% of its $368M portfolio in Q1 2025.
- Virtus Investment Advisers opened 414 new positions and closed 237 in Q1 2025.
- Virtus Investment Advisers's portfolio value rose 188% quarter-over-quarter to $368M.
Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.